HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Soots, G. Articles by Devulder, J. P. Search for Related Content PubMed PubMed Citation Articles by Soots, G. Articles by Devulder, J. P.

European Journal of Cardio-Thoracic Surgery, Vol 5, 400-404, Copyright © 1991 by European Association for Cardio-thoracic Surgery

ARTICLES

Cold blood cardioplegia and warm cardioplegic reperfusion in heart transplantation

G Soots, F Crepin, A Prat, B Gosselin, A Pol, D Moreau and JP Devulder
Hopital Cardiologique, University of Lille, France.

The major cause of early death after heart transplantation is graft failure. In 99 consecutive heart transplantations two protocols of myocardial protection were employed. In group 1 (n = 38) initial cold crystalloid cardioplegia combined with cold saline storage and peroperative surface cooling was used. In group 2 (n = 61) cold crystalloid cardioplegia was injected initially and cold blood cardioplegia (Buckberg) was infused every 30 min as soon as the graft arrived in the operating room. No surface cooling was used. Warm blood cardioplegic reperfusion was administered before removal of the aortic clamp. There were 8 early (within 30 days) deaths in group 1 and 6 in group 2 patients. In group 1 there were 5 cardiac deaths against 3 in group 2. Mean ischemic time was 153 +/- 37 min in group 1 and 158 +/- 51 min (p greater than 0.05) in group 2. The post-transplantation need for catecholamines was ten times higher in group 1 patients than in group 2. The first endomyocardial biopsy (after 1 week) showed cytologic lesions compatible with ischemia in 40% of group 1 and only 9% in group 2 patients. We conclude from this initial experience that intermittent cold blood cardioplegia and warm blood cardioplegic reperfusion are useful in heart transplantation in restoring the damage suffered by the graft during brain death and graft storage.

This article has been cited by other articles:

				J. Martin, G. Lutter, C. Ihling, M. Siepe, S. Wagner, J. Hilberath, M. Kemper, K. Sarai, and F. Beyersdorf Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart-beating donors J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1217 - 1228. [Abstract] [Full Text] [PDF]

				G. B. Luciani, G. Faggian, G. Montalbano, G. Casali, A. Forni, B. Chiominto, and A. Mazzucco BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA FOR MYOCARDIAL PROTECTION OF DONOR HEARTS DURING TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 787 - 795. [Abstract] [Full Text] [PDF]

				G. Pradas, J. Cuenca, and A. Juffe CONTINUOUS WARM REPERFUSION DURING HEART TRANSPLANTATION J. Thorac. Cardiovasc. Surg., April 1, 1996; 111(4): 784 - 790. [Abstract] [Full Text]